Home
CVAC
CVAC News

Latest CureVac N.V. (CVAC) News on July 3, 2025

CureVac Announces Voting Results of General Meeting

ACCESS Newswire

8 days ago

CureVac Announces Voting Results of General Meeting

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech

Zacks

13 days ago

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech

Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz

TipRanks

20 days ago

Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz

BioNTech buys mRNA, courtroom rival CureVac in all-stock deal

BioPharma Dive

20 days ago

BioNTech buys mRNA, courtroom rival CureVac in all-stock deal

MT Newswires

20 days ago

Jefferies Downgrades CureVac to Hold From Buy, $5 Price Target

Stocks to Watch Recap: Boeing, Oracle, GE Aerospace, GameStop

The Wall Street Journal

20 days ago

Stocks to Watch Recap: Boeing, Oracle, GE Aerospace, GameStop

MT Newswires

20 days ago

Top Midday Gainers

MT Newswires

21 days ago

Sector Update: Health Care

BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition

Pharmaceutical Technology

21 days ago

BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition

Gold prices, BioNTech to acquire CureVac, Tapestry upgrade

Yahoo Finance Video

21 days ago

Gold prices, BioNTech to acquire CureVac, Tapestry upgrade

Top Stock Movers Now: Oracle, Boeing, CureVac, and More

Investopedia

21 days ago

Top Stock Movers Now: Oracle, Boeing, CureVac, and More

MT Newswires

21 days ago

Top Midday Stories: Boeing Shares Fall After Air India Plane Crash; Oracle Q4 Results Top Expectations

We Think CureVac's (NASDAQ:CVAC) Robust Earnings Are Conservative

Simply Wall St.

a month ago

We Think CureVac's (NASDAQ:CVAC) Robust Earnings Are Conservative

CureVac First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

a month ago

CureVac First Quarter 2025 Earnings: Misses Expectations

Earnings Beat: CureVac N.V. (NASDAQ:CVAC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.

a month ago

Earnings Beat: CureVac N.V. (NASDAQ:CVAC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates

ACCESS Newswire

a month ago

CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates

May 2025's Promising Penny Stocks To Consider

Simply Wall St.

2 months ago

May 2025's Promising Penny Stocks To Consider

MT Newswires

2 months ago

UBS Trims Price Target on CureVac to $12 From $13, Maintains Buy Rating

CureVac Among 3 Promising Penny Stocks To Watch

Simply Wall St.

3 months ago

CureVac Among 3 Promising Penny Stocks To Watch

Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz

TipRanks

3 months ago

Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz

CureVac NV (CVAC) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial Resilience

GuruFocus.com

3 months ago

CureVac NV (CVAC) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial Resilience

Thomson Reuters StreetEvents

3 months ago

Q4 2024 CureVac NV Earnings Call

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update

ACCESS Newswire

3 months ago

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update

CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025

ACCESS Newswire

3 months ago

CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025

FDA clears CureVac’s IND application for Phase I lung cancer trial

Clinical Trials Arena

3 months ago

FDA clears CureVac’s IND application for Phase I lung cancer trial

MT Newswires

3 months ago

CureVac Receives FDA Clearance to Initiate Phase 1 Trial of Lung Cancer Therapy

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer

ACCESS Newswire

3 months ago

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer

Is CureVac (CVAC) the Best German Stock to Buy According to Hedge Funds?

Insider Monkey

3 months ago

Is CureVac (CVAC) the Best German Stock to Buy According to Hedge Funds?

Lululemon reports Q4 beat, CoreWeave IPO priced at $40: Morning Buzz

TipRanks

3 months ago

Lululemon reports Q4 beat, CoreWeave IPO priced at $40: Morning Buzz

MT Newswires

3 months ago

Sector Update: Health Care

MT Newswires

3 months ago

CureVac Patent Validated in BioNTech Dispute, Infringement Hearing Set for July

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

ACCESS Newswire

3 months ago

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

CureVac N.V.'s (NASDAQ:CVAC) largest shareholders are individual investors with 38% ownership, private equity firms own 31%

Simply Wall St.

4 months ago

CureVac N.V.'s (NASDAQ:CVAC) largest shareholders are individual investors with 38% ownership, private equity firms own 31%

Is CureVac N.V. (CVAC) the Best Get Rich Fast Stock to Buy Now?

Insider Monkey

4 months ago

Is CureVac N.V. (CVAC) the Best Get Rich Fast Stock to Buy Now?

CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators

ACCESS Newswire

4 months ago

CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators

Discovering Giftify And 2 Other US Penny Stocks With Promising Potential

Simply Wall St.

5 months ago

Discovering Giftify And 2 Other US Penny Stocks With Promising Potential

Companies Like CureVac (NASDAQ:CVAC) Are In A Position To Invest In Growth

Simply Wall St.

5 months ago

Companies Like CureVac (NASDAQ:CVAC) Are In A Position To Invest In Growth

Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus

Yahoo Finance

6 months ago

Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus

Moderna stock seesaws as first US bird flu death puts vaccine development in focus

Yahoo Finance

6 months ago

Moderna stock seesaws as first US bird flu death puts vaccine development in focus

Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death

Zacks

6 months ago

Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death

Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death

Barrons.com

6 months ago

Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death

Discover 3 US Penny Stocks With Market Caps Over $200M

Simply Wall St.

6 months ago

Discover 3 US Penny Stocks With Market Caps Over $200M

Cerus And 2 Other US Penny Stocks To Watch

Simply Wall St.

7 months ago

Cerus And 2 Other US Penny Stocks To Watch

Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven

Simply Wall St.

7 months ago

Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven

Is the Options Market Predicting a Spike in CureVac (CVAC) Stock?

Zacks

7 months ago

Is the Options Market Predicting a Spike in CureVac (CVAC) Stock?

Is CureVac N.V. (CVAC) the Best German Stock to Buy Now?

Insider Monkey

7 months ago

Is CureVac N.V. (CVAC) the Best German Stock to Buy Now?

Where are they now? 4 biotechs that soared then crashed during the pandemic

Pharma Voice

8 months ago

Where are they now? 4 biotechs that soared then crashed during the pandemic

CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...

GuruFocus.com

8 months ago

CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

ACCESSWIRE

8 months ago

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024

ACCESSWIRE

8 months ago

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024

MT Newswires

8 months ago

CureVac Appoints Axel Sven Malkomes as CFO

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer

ACCESSWIRE

8 months ago

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer

CureVac to Present at the 12th International mRNA Health Conference

ACCESSWIRE

8 months ago

CureVac to Present at the 12th International mRNA Health Conference

US Penny Stocks To Watch In October 2024

Simply Wall St.

8 months ago

US Penny Stocks To Watch In October 2024

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness

The Wall Street Journal

8 months ago

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

ACCESSWIRE

8 months ago

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Morningstar Research

8 months ago

Analyst Report: CureVac N.V.

MT Newswires

9 months ago

Pfizer, BioNTech Win Legal Dispute Against CureVac's UK COVID Patents

Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents

Reuters

9 months ago

Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents

CureVac N.V.'s (NASDAQ:CVAC) top owners are individual investors with 35% stake, while 31% is held by private equity firms

Simply Wall St.

9 months ago

CureVac N.V.'s (NASDAQ:CVAC) top owners are individual investors with 35% stake, while 31% is held by private equity firms

MT Newswires

10 months ago

CureVac Says CVGBM Cancer Vaccine Induces 77% T-Cell Response in Early-Stage Trial in Glioblastoma

CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress

ACCESSWIRE

10 months ago

CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress

GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal

Zacks

10 months ago

GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program

ACCESSWIRE

10 months ago

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program

CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress

ACCESSWIRE

10 months ago

CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress

News Flash: 8 Analysts Think CureVac N.V. (NASDAQ:CVAC) Earnings Are Under Threat

Simply Wall St.

10 months ago

News Flash: 8 Analysts Think CureVac N.V. (NASDAQ:CVAC) Earnings Are Under Threat

CureVac Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

10 months ago

CureVac Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Morningstar Research

a year ago

Analyst Report: CureVac N.V.

MT Newswires

a year ago

CureVac Doses First Patient in Part B of Cancer Vaccine Candidate Study

MT Newswires

a year ago

CureVac's Q2 Pre-Tax Loss Widens, Revenue Rises; Finance Chief Pierre Kemula to Depart

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update

ACCESSWIRE

a year ago

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update

CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma

ACCESSWIRE

a year ago

CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma

CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board

ACCESSWIRE

a year ago

CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board

CorMedix (CRMD) Reports Q2 Loss, Tops Revenue Estimates

Zacks

a year ago

CorMedix (CRMD) Reports Q2 Loss, Tops Revenue Estimates

CureVac N.V. (CVAC) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

a year ago

CureVac N.V. (CVAC) Expected to Beat Earnings Estimates: Should You Buy?

We Think CureVac (NASDAQ:CVAC) Can Afford To Drive Business Growth

Simply Wall St.

a year ago

We Think CureVac (NASDAQ:CVAC) Can Afford To Drive Business Growth

CureVac (CVAC) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

a year ago

CureVac (CVAC) Upgraded to Buy: What Does It Mean for the Stock?

MT Newswires

a year ago

CureVac Provides Trial Dates for Patent Litigation Against Pfizer, BioNTech

CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech

ACCESSWIRE

a year ago

CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech

An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued

Simply Wall St.

a year ago

An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued

Morningstar Research

a year ago

Analyst Report: CureVac N.V.

GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac

Zacks

a year ago

GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac

Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More

Zacks

a year ago

Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More

CureVac announces restructuring to focus on mRNA projects

Pharmaceutical Technology

a year ago

CureVac announces restructuring to focus on mRNA projects

MT Newswires

a year ago

Sector Update: Health Care Stocks Fall in Afternoon Trading

GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines

Investopedia

a year ago

GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines

MT Newswires

a year ago

Sector Update: Health Care

GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines

Barrons.com

a year ago

GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines

Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine

Zacks

a year ago

Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine

MT Newswires

a year ago

Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

MT Newswires

a year ago

Sector Update: Health Care

GSK to Buy COVID-19, Flu Vaccine Rights From CureVac for $1.56 Billion

MT Newswires

a year ago

GSK to Buy COVID-19, Flu Vaccine Rights From CureVac for $1.56 Billion

CureVac cuts jobs, licenses out vaccines to GSK

BioPharma Dive

a year ago

CureVac cuts jobs, licenses out vaccines to GSK

GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion

The Wall Street Journal

a year ago

GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion

GSK and CureVac restructure mRNA vaccine development deal

Pharmaceutical Technology

a year ago

GSK and CureVac restructure mRNA vaccine development deal

MT Newswires

a year ago

CureVac Enters Into New Licensing Agreement With GSK; to Implement 'Significant' Restructuring; Shares Rise Pre-Bell

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

ACCESSWIRE

a year ago

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities

ACCESSWIRE

a year ago

CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities

GSK buys COVID, influenza vaccines from retrenching CureVac

Reuters

a year ago

GSK buys COVID, influenza vaccines from retrenching CureVac

CureVac Announces Voting Results of General Meeting

ACCESSWIRE

a year ago

CureVac Announces Voting Results of General Meeting

Share on Social Networks: